|

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

RECRUITINGN/ASponsored by University of Pittsburgh
Actively Recruiting
PhaseN/A
SponsorUniversity of Pittsburgh
Started2026-02-16
Est. completion2026-12
Eligibility
Age16 Years – 24 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07270016

Summary

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

Eligibility

Age: 16 Years – 24 YearsHealthy volunteers accepted
Inclusion criteria:

* Ages 16-24 years, any sex or gender
* Diagnosis of type 2 diabetes in childhood (younger than 18 years of age)
* English-speaking (app in English)
* Possession of personal smartphone that is compatible with FreeStyle Libre app

Exclusion Criteria:

• Cognitive impairment or severe psychiatric conditions that could interfere with participation in behavioral intervention for diabetes self-management

Conditions6

Continuous Glucose MonitoringDiabetesDiabetes Mellitus, Type 2HyperglycemiaLifestyle (Sedentary Behavior and Physical Activity)Physical Inactivity

Locations1 site

Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224
Mary Ellen Vajravelu, MD, MSHP412-692-6533MaryEllen.Vajravelu@pitt.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.